ITEMS IN AFP WITH KEYWORD:

Gastroesophageal Reflux Disease

Oct 1, 2003 Issue
Management of Gastroesophageal Reflux Disease [Article]

The primary treatment goals in patients with gastroesophageal reflux disease are relief of symptoms, prevention of symptom relapse, healing of erosive esophagitis, and prevention of complications of esophagitis. In patients with reflux esophagitis, treatment is directed at acid suppression through t...


Sep 15, 2003 Issue
Evaluation of Epigastric Discomfort and Management of Dyspepsia and GERD [Practice Guidelines]

The Institute for Clinical Systems Improvement (ICSI) recently published a guideline on the evaluation and management of dyspepsia and gastroesophageal reflux disease (GERD).


Jul 15, 2002 Issue
Proton Pump Inhibitors: An Update [Article]

Since their introduction in the late 1980s, proton pump inhibitors have demonstrated gastric acid suppression superior to that of histamine H2-receptor blockers. Proton pump inhibitors have enabled improved treatment of various acid-peptic disorders, including gastroesophageal reflux disease, peptic...


Dec 1, 2001 Issue
Gastroesophageal Reflux in Infants and Children [Article]

Gastroesophageal reflux is a common, self-limited process in infants that usually resolves by six to 12 months of age. Effective, conservative management involves thickened feedings, positional treatment, and parental reassurance. Gastroesophageal reflux disease (GERD) is a less common, more serious...


Sep 1, 1999 Issue
Head and Neck Manifestations of Gastroesophageal Reflux Disease [Article]

Gastroesophageal reflux disease (GERD) is the most common esophageal disease. Besides the typical presentation of heartburn and acid regurgitation, either alone or in combination, GERD can cause atypical symptoms. An estimated 20 to 60 percent of patients with GERD have head and neck symptoms withou...


Mar 1, 1999 Issue
Gastroesophageal Reflux Disease: Diagnosis and Management [Article]

Gastroesophageal reflux disease (GERD) is a chronic, relapsing condition with associated morbidity and an adverse impact on quality of life. The disease is common, with an estimated lifetime prevalence of 25 to 35 percent in the U.S. population. GERD can usually be diagnosed based on the clinical pr...


Pages: Previous 1 2 3


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now